Pancreatic Cancer Research

ResearcherStony Brook UniversityNo recent work listed

George Mattheolabakis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6246-8421; OpenAlex author ID A5012625975. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper

Papers 6

  1. Combination of miR‑143 and miR‑506 reduces lung and pancreatic cancer cell growth through the downregulation of cyclin‑dependent kinases. Last author DOI 10.3892/or.2021.7953↗
  2. In vitro model of inflammatory, hypoxia, and cancer stem cell signaling in pancreatic cancer using heterocellular 3-dimensional spheroids First author DOI 10.1101/454397↗
  3. [Corrigendum] Phospho‑valproic acid inhibits pancreatic cancer growth in mice: Enhanced efficacy by its formulation in poly‑(L)‑lactic acid‑poly(ethylene glyco… Co-author DOI 10.3892/ijo.2018.4584↗
  4. Phospho-valproic acid inhibits pancreatic cancer growth in mice: enhanced efficacy by its formulation in poly-(L)-lactic acid-poly(ethylene glycol) nanoparticl… Co-author DOI 10.3892/ijo.2017.4103↗
  5. EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model. Co-author DOI 10.1016/j.nano.2015.11.010↗
  6. Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice. Co-author DOI 10.1371/journal.pone.0061532↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gerardo Guillermo Mackenzie · 4 shared papers, 2013–2021 · strength 0.48
  2. Basil Rigas · 3 shared papers, 2013–2018 · strength 0.26
  3. A K M Nawshad Hossian · 1 shared paper, 2021 · strength 0.22
  4. Mansoor M. Amiji · 2 shared papers, 2016–2018 · strength 0.20
  5. Amit Singh · 2 shared papers, 2016–2018 · strength 0.20
  6. Megha Suresh · 1 shared paper, 2018 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.